| RS2133411551 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133411704 |
LIPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Wolman disease, Lysosomal acid lipase deficiency |
| RS2133411859 |
LIPA
|
Health Risk |
Likely pathogenic |
Wolman disease, Wolman disease |
| RS2133412083 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Wolman disease |
| RS2133412405 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133412472 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133413584 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Lysosomal acid lipase deficiency |
| RS2133413622 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133424815 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Wolman disease |
| RS2133427073 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Wolman disease |
| RS2133427390 |
RINT1
|
Health Risk |
Likely pathogenic |
— |
| RS2133429402 |
LIPA
|
Health Risk |
Pathogenic |
Lysosomal acid lipase deficiency, Lysosomal acid lipase deficiency |
| RS2133429462 |
LIPA
|
Health Risk |
Likely pathogenic |
Wolman disease, Cholesteryl ester storage disease |
| RS2133429569 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Wolman disease |
| RS2133430623 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133433678 |
GSN
|
Health Risk |
Pathogenic |
Finnish type amyloidosis, Finnish type amyloidosis |
| RS2133436727 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysosomal acid lipase deficiency, Wolman disease |
| RS2133439017 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133440581 |
ECHS1
|
Health Risk |
Likely pathogenic |
— |
| RS2133441975 |
ECHS1
|
Health Risk |
Likely pathogenic |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS2133443188 |
ECHS1
|
Health Risk |
Pathogenic |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS2133443370 |
ECHS1
|
Health Risk |
Likely pathogenic |
ECHS1-related disorder, ECHS1-related disorder |
| RS2133449474 |
HTRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
CARASIL syndrome, Cerebral arteriopathy |
| RS2133450404 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2133450854 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2133453300 |
FKTN
|
Health Risk |
Likely pathogenic |
— |
| RS2133453431 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS2133453577 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133454296 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS2133456150 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2133457292 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133458164 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133460799 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133460957 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133463883 |
RINT1
|
Health Risk |
Pathogenic |
— |
| RS2133468001 |
LIPA
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2133468040 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Wolman disease |
| RS2133472134 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133473949 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS2133473953 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133477788 |
RINT1
|
Health Risk |
Pathogenic |
— |
| RS2133479924 |
RINT1
|
Health Risk |
Pathogenic |
— |
| RS2133480858 |
ACADSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of 2-methylbutyryl-CoA dehydrogenase, Deficiency of 2-methylbutyryl-CoA dehydrogenase |
| RS2133482258 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS2133484638 |
ACADSB
|
Health Risk |
Likely pathogenic |
Deficiency of 2-methylbutyryl-CoA dehydrogenase, Deficiency of 2-methylbutyryl-CoA dehydrogenase |
| RS2133487890 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2133499883 |
EPS8L2
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 106 |
| RS2133502090 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133503091 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133503921 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133504109 |
FAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133508524 |
CSRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1M, Hypertrophic cardiomyopathy 12 |
| RS2133510569 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133510708 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133510772 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133511280 |
CSRP3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 12, Dilated cardiomyopathy 1M |
| RS2133511511 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133515017 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133516329 |
CSRP3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 12, Dilated cardiomyopathy 1M |
| RS2133516584 |
CSRP3
|
Health Risk |
Likely pathogenic |
— |
| RS2133527951 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133529359 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133537931 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS2133539303 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Diabetes mellitus |
| RS2133539468 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133545024 |
CD59
|
Health Risk |
Pathogenic |
Primary CD59 deficiency, Primary CD59 deficiency |
| RS2133545231 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS2133545475 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Ovarian cancer |
| RS2133547404 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133548955 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133554613 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133559667 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133560140 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133560305 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133560315 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS2133560394 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133560406 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133577022 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133577213 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133577966 |
FREM1
|
Health Risk |
Likely pathogenic |
— |
| RS2133582387 |
IGF2
|
Health Risk |
Likely pathogenic |
— |
| RS2133585000 |
IGF2;INS-IGF2
|
Health Risk |
Likely pathogenic |
— |
| RS2133587981 |
HBB
|
Health Risk |
Likely pathogenic |
beta Thalassemia, beta Thalassemia |
| RS2133588176 |
HBB
|
Health Risk |
Likely pathogenic |
beta Thalassemia, Beta-thalassemia HBB/LCRB |
| RS2133588679 |
HBB
|
Health Risk |
Likely pathogenic |
Hemoglobinopathy, Hemoglobinopathy |
| RS2133588734 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS2133589044 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2133589910 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133591810 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133591953 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133592454 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133592586 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS2133593245 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133593509 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS2133593569 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133593716 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133594187 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133594398 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS2133594431 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133595741 |
ABCC8
|
Health Risk |
Pathogenic |
— |